Steroid resistant nephrotic syndrome: Is sustained remission attainable

Indian Pediatrics

Volumn 43, Issue 1, 2006, Pages 39-43

  Nammalwar, B R ^a   Vijaykumar, M ^a   Prahlad, N ^a   Jain, Dilipkumar V ^a  

^a KANCHI KAMAKOTI CHILDS TRUST HOSPITAL   (India)

Author keywords

Cyclophosphamid; Methyl prednisolone; Steroid resistant nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ABSENCE OF SIDE EFFECTS; ARTICLE; CELLULITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DYSURIA; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HAIR GROWTH; HEMORRHAGIC CYSTITIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DYSFUNCTION; LEUKOPENIA; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PNEUMONIA; PRESCHOOL CHILD; PROLIFERATIVE GLOMERULONEPHRITIS; PROSPECTIVE STUDY; REMISSION; SEPTICEMIA; SKIN INFECTION; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 32644432692     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ponticelli C, Passerini P. Treatment of nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 1994; 46: 595-604.
2. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change neprotic syndrome from initial response to prednisone. J Pediatr 1981, 98: 561-564.
3. Yorgin PD, Krasher J, Ali-Uzri AY. Pulse methylprednisolone preatment of idiopathic steroid-resistant nephrotic syndrome. Pediatr Nephrol 2001; 16: 245-250.
4. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tunne BM. Treatment steroid resistant focal segmental glomerulosclrosis with pulse methylprednisolone and ankylating agents. Pediatr Nephrol 1990; 4: 303-307.
5. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA. Intravenous methylprednisolone and oral ankylatimg agent therapy of prednisone-resistant pediatric focal segmental glomeruloclerosis: A long-term follow-up. Clin Nephrol. 1995; 43: 84-88.
6. Hari P, Bagga A, Jindal N, Srivastava RN. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol 2001; 16: 901-905.
7. Gulati S, Kher V. Intravenous pulse cyclophosphamide - a new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatr 2000; 37: 141-148.
8. Vecsei AK, Muller T, Schratzberger EC, Kircher K, Regele H, Arbeiter K, et al. Plasmapheresis-induced remission in otherwise therapy-resistant FSGS. Pediatr Nephrol 2001; 16: 898-900.
9. Niaudet P for French Society of Pediatric Nephrology Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone. J Pediatr 1994; 125: 981-986.
10. Lieberman KV, Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996; 7: 56-63.
11. Goonasekera CD, Koziell AB, Hulton SA, Dillon MJ. Vincristine and focal segmental sclerosis: Do we need a multicentre trial? PediatrNephrol1998; 12: 284-289.
12. Schweda F, Liebl R, Riegger GA, Kramer BK. Tacrolimus treatment for steroid and cyclosporin resistant minimal-change nephrotic syndrome. Nephrol Dial Transplant 1997; 12: 2433-2435.
13. ISKDC. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978; 13: 159-165.
14. White RH, Glasgow EF, Mills RJ. Clinicopathological study of nephrotic syndrome in childhood. Lancet 1970; 27: 1353-1359.
15. Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S. Pulse cyclophosphamide for steroid-resistant focal and segmental glomerulosclerosis. Pediatr Nephrol 1999; 13: 113-116.
16. Adhikari M, Bhimma R, Coovadia HM. Intensive pulse therapies for focal glomerulosclerosis in South African children. Pediatr Nephrol 1997; 11: 423-428.
17. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK. Intravenous pulse cyclophosphamide -A new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol 1994; 8: 1-3.
18. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatr Nephrol, 2003; 18: 351-356.